Opioid Analgesic (Weak-Moderate) / SNRI
Pregnancy: Avoid prolonged use and near delivery — neonatal withdrawal, respiratory depression
Tramadol
Brand names: Zamadol, Tramquel, Tilodol SR
Adult dose
Dose: Immediate release: 50–100 mg every 4–6 hours. Modified release: 100–200 mg BD. Maximum: 400 mg/day.
Route: Oral (or IV in hospital)
Frequency: QDS (IR) or BD (MR)
Max: 400 mg/day (300 mg/day in elderly)
Dual mechanism: weak mu-opioid agonist + serotonin/noradrenaline reuptake inhibition. Serotonin syndrome risk with SSRIs, SNRIs, MAOIs, triptans. Lowers seizure threshold.
Paediatric dose
Dose: 1 mg/kg
Route: Oral or IV
Frequency: Every 4–6 hours PRN
Max: 400 mg/day
Concentration: 50 mg/mL injection; 50 mg capsules mg/ml
Licensed for children ≥12 years. Use with caution. Not recommended in children <12 years.
Dose adjustments
Renal
Maximum 200 mg/day if eGFR <30; increase dosing interval to every 12 hours
Hepatic
Maximum 200 mg/day in hepatic impairment; increase dosing interval
Paediatric weight-based calculator
Licensed for children ≥12 years. Use with caution. Not recommended in children <12 years.
Clinical pearls
- Serotonin syndrome warning: tramadol + SSRI combination is common and potentially dangerous — assess risk in all patients
- Lower seizure threshold: avoid in patients with epilepsy; risk further increased with SSRIs
- Withdrawal syndrome occurs with abrupt discontinuation — taper dose
- Not a GABA-B agonist like gabapentinoids — different mechanism from pregabalin/gabapentin despite occasional prescribing in similar pain contexts
Contraindications
- Concurrent MAOIs or within 14 days of stopping
- Uncontrolled epilepsy
- Respiratory depression
- Acute alcohol/opioid/psychotropic drug intoxication
Side effects
- Nausea/vomiting (common — premedicate with metoclopramide)
- Dizziness
- Constipation (less than codeine)
- Seizures (especially with SSRIs)
- Serotonin syndrome (with SSRIs, MAOIs)
- Dependence/withdrawal
- Sweating
Interactions
- SSRIs/SNRIs — serotonin syndrome risk (significant interaction)
- MAOIs — severe serotonin syndrome (absolutely contraindicated)
- Carbamazepine — reduces tramadol efficacy and increases seizure risk
- Warfarin — may enhance anticoagulant effect (monitor INR)
- Antidepressants — multiple serotonergic interactions
Monitoring
- Pain scores
- Nausea (consider anti-emetic cover)
- Neurological symptoms (serotonin syndrome: hyperthermia, clonus, agitation)
- Seizure risk assessment
Reference: BNFc; BNF; MHRA Drug Safety Update on Serotonin Syndrome. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Morphine Milligram Equivalents (MME) Calculator · Pain / Opioids
- Opioid Conversion / Equianalgesic Guide · Pain Management
- Numeric Rating Scale (NRS) Pain Assessment and Management · Pain Management
- Finnegan Neonatal Abstinence Scoring Tool (FNAST) · Neonatal Abstinence Syndrome
- Modified Finnegan Neonatal Abstinence Score (NAS) · Neonatal
- Withdrawal Assessment Tool (WAT-1) for Paediatric Iatrogenic Withdrawal · Critical Care